Poseida News Center

Read media coverage on Poseida, find resources for the working press, and get insights from our executive leadership team on the next wave of cell and gene therapies.

Featured Content

Providing new hope for rare disease using non-viral gene therapy

Providing new hope for rare disease using non-viral gene therapy

Drug Target Review | June 20, 2022

Novel cell and gene therapies, Mark Gergen, CEO, Poseida Therapeutics, Inc.

Novel cell and gene therapies,
Mark Gergen, CEO, Poseida Therapeutics, Inc.

Biotech 2050 Podcast | July 13, 2022

Spotlight on Poseida’s CAR-T Strategy

Spotlight on Poseida’s CAR-T Strategy

Celltelligence | June 22, 2022

Executive Perspectives

Our Understanding of Immunology and Immunotherapy in Cancer Care and Beyond

Our Understanding of Immunology and Immunotherapy in Cancer Care and Beyond

LinkedIn | June 8, 2022

Executive Perspectives - Eric Ostertag

Poseida Therapeutics: Creating the Next Wave of Cell & Gene Therapies With the Capacity to Cure

By Eric Ostertag, M.D., Ph.D., Executive Chairman
Drug Development & Delivery | September 1, 2021

Executive Perspectives - Kerry Ingalls

Keys to the Successful Preclinical-Clinical Translation of Next-Gen CAR-T Cell Therapy

By Devon Shedlock, Ph.D., Chief Scientific Officer, Cell Therapies
Cell & Gene Therapy Insights | February 8, 2022 (registration required)

Media Library

Usage rights & restrictions: These media assets are free for editorial broadcast, print, online and radio use. They are restricted for other purposes.
If you are a member of the working press and need a resource that is not available on this website, please e-mail your request to sthailing@poseida.com and we will make every effort to respond as soon as possible.

Corporate Images

Headshots

Logos

MENU